SEC Form 4 · accession 0001209191-18-044943
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeryl L Hilleman
Director
Period of report
Jul 31, 2018
Accepted (ET)
Aug 2, 2018 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF1 | $34.00 | Jul 31, 2018 | A | 37,101 | A | — | Jul 30, 2028 | Ordinary Shares | 37,101 | 37,101 | D |
Explanation of responses
- F1This stock option will vest in equal parts on the earlier of each of the following dates: (i) the first, second and third anniversary of the grant date and (ii) the day immediately preceding of the Company's 2019, 2020 and 2021 annual general meeting of shareholders, respectively.